We use analytics and advertising cookies, which you can accept or reject; see our privacy policy.

Current choice:

Phosphorylases

Phosphorylase inhibitors act on glycogen and thymidine phosphorylases, which cleave bonds by phosphorolysis. Glycogen phosphorylase releases glucose 1-phosphate from glycogen and controls the rate of glycogen breakdown in liver and muscle. CP-91149, reported in 1998, inhibits human liver glycogen phosphorylase and lowered blood glucose in diabetic mice. Ingliforib, BAY R3401 and GPi688 are further glycogen phosphorylase inhibitors for studies of hepatic glucose output. Thymidine phosphorylase converts thymidine to thymine and was identified in 1992 as the angiogenic platelet-derived endothelial cell growth factor. Tipiracil hydrochloride inhibits this enzyme, whereas doxifluridine is a fluoropyrimidine prodrug that thymidine phosphorylase activates.

1 Item

  • Doxifluridine
    Cat. No.
    A11847
    CAS No.
    3094-09-5

    Doxifluridine

    Synonyms: Ro 21-9738; 5-Fluoro-5'-deoxyuridine; 5'-DFUR

    Doxifluridine is a thymidine phosphorylase activator for PC9-DPE2 cells with IC50 of 0.62 μM.

    In stock View Details
    500 mg
    $20.00
    1 g
    $35.00
    All 3 sizes

1 Item

Added to your cart

View Cart Checkout

    Loading...